The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinicopathological relationships

Brain

Volumn 134, Issue 9, 2011, Pages 2478-2492

  Snowden, Julie S ^a,b   Thompson, Jennifer C ^a,b   Stopford, Cheryl L ^a,b   Richardson, Anna M T ^a,b   Gerhard, Alex ^a,b   Neary, David ^a,b   Mann, David M A ^b  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer's disease; frontotemporal dementia; frontotemporal lobar degeneration; neuropathology; progressive aphasia

Indexed keywords

TAR DNA BINDING PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; APRAXIA; ARTICLE; BEHAVIOR; CADAVER; COGNITION; CORTICOBASAL DEGENERATION; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MOTOR NEURON DISEASE; NEUROLOGIC EXAMINATION; ONSET AGE; PATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; SEMANTIC DEMENTIA; SENSITIVITY AND SPECIFICITY;

EID: 80052953769     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr189     Document Type: Article

References (112)

1. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR. Focal cortical presentations of Alzheimer's disease. Brain 2007; 130: 2636-45. (Pubitemid 47511719)
2. Amador-Ortiz C, Lin W-L, Ahmed Z, Personett D, Davies P, Duara R, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007; 61: 435-45. (Pubitemid 46878771)
3. Amici S, Gorno-Tempini M-L, Ogar JM, Dronkers NF, Miller BL. An overview of primary progressive aphasia and its variants. Behav Neurol 2006; 17: 77-87. (Pubitemid 44078630)
4. Arai T, Mackenzie IRA, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2009; 117: 125-36.
5. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in Progranulin cause tau-negative fron-totemporal dementia linked to chromosome 17. Nature, 2006; 442, 916-19. (Pubitemid 44285946)
6. Bathgate D, Snowden JS, Varma A, Blackshaw A, Neary D. Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001; 103: 367-78. (Pubitemid 32531137)
7. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
8. Brunnström H, Englund E. Clinicopathological concordance in dementia diagnostics. Am J Geriatr Psychiatry 2009; 17: 664-70.
9. Brunnström H, Gustafson L, Passant U, Englund E. Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports. Arch Gerontol Geriatr 2009; 49: 146-9.
10. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiano O, Gullotta F, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 459-66.
11. Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007; 114: 2-22.
12. Crystal MA, Horoupian DS, Katzman R, Jotkowitz S. Biopsy-proved Alzheimer's disease presenting as a right parietal syndrome. Ann Neurol 1982; 12: 186-8. (Pubitemid 12097697)
13. Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology 2010; 74: 42-9.
14. Dick J, Snowden JS, Goulding PJ, Northen B, Neary D. Slowly progressive apraxia. Behav Neurol 1989; 2: 101-14.
15. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935-46. (Pubitemid 35278715)
16. Didic M, Ali Cherif A, Gambarelli D, Poncet M, Boudouresques JA. A permanent pure amnestic syndrome of insidious onset related to Alzheimer's disease. Ann Neurol 1998; 43: 526-9.
17. Doubleday EK, Snowden JS, Varma AR, Neary D. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72: 602-7. (Pubitemid 34462814)
18. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-46. (Pubitemid 47058377)
19. Fisher NJ, Rourke BP, Bieliauskas L, Giordani B, Berent S, Foster N. Neuropsychological subgroups of patients with Alzheimer's disease. J Clin Exp Neuropsychol 1996; 18: 349-70. (Pubitemid 26297746)
20. Fisher NJ, Rourke BP, Bieliauskas LA. Neuropsychological subgroups of patients with Alzheimer's disease: an examination of the first 10 years of CERAD data. J Clin Exp Neuropsychol 1999; 21: 488-518.
21. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59: 952-62. (Pubitemid 43830927)
22. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 1983; 33: 961-5. (Pubitemid 13030175)
23. Fraser E, McDonagh AM, Head M, Bishop M, Ironside JW, Mann DMA. Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies. Neuropathol Appl Neurobiol 2003; 29: 482-95. (Pubitemid 37222722)
24. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000; 123: 484-98. (Pubitemid 30099534)
25. Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, et al. Pathological 43-kDa transactivation response DNA-binding protein in older adult with and without severe mental illness. Arch Neurol 2010; 67: 1238-50.
26. Gorno-Tempini M-L, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008; 71: 1227-34.
27. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy of three variants of primary progressive aphasia. Ann Neurol 2004; 55: 335-46. (Pubitemid 38269585)
28. Green RC, Goldstein FC, Mirra SS, Alazraki NP, Baxt JL, Bakay RA. Slowly progressive apraxia in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995; 59: 312-5.
29. Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol 2010; 6: 88-97.
30. Gutierrez-Galve L, Lehmann M, Hobbs NZ, Clarkson MJ, Ridgway GR, Crutch S, et al. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease. Dement Geriatr Cogn Disord 2009; 28: 476-85.
31. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001; 57: 1461-6. (Pubitemid 32995729)
32. Hassan A, Whitwell JL, Boeve BF, Jack CR Jr, Parisi JE, Dickson DW, et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord 2010; 16: 208-14.
33. Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain 1992; 115: 1783-806. (Pubitemid 23054865)
34. Hof PR, Archin N, Osmand AP, Dougherty JH, Wells C, Bouras C, et al. Posterior cortical atrophy in Alzheimer's disease-analysis of a new case and re-evaluation of a historical report. Acta Neuropathol 1993; 86: 215-23. (Pubitemid 23275938)
35. Hof PR, Bouras C, Constantinidis J, Morrison JH. Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropath Exp Neurol 1990; 49: 168-84. (Pubitemid 20111963)
36. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174: 45-50. (Pubitemid 29037883)
37. Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, Petersen RC, et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer's disease. Acta Neuropathol 2008; 116: 215-20.
38. Hu WT, Rippon GW, Boeve BF, Knopman DS, Peterson RC, Parisi JE, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009; 24: 1375-9.
39. Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 1988; 38: 909-12.
40. Jellinger KA. Clinicopathological analysis of dementia disorders in the elderly-an update. J Alzheimers Dis 2006; 9: 61-70. (Pubitemid 44253299)
41. Johnson JK, Head E, Kim R, Star A, Cotman CW. Clinical and pathological evidence for a frontal variant of Alzheimer's disease. Arch Neurol 1999; 56: 1233-9. (Pubitemid 29473215)
42. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006b; 129: 1385-98. (Pubitemid 43999372)
43. Josephs K, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 2011; 122: 137-53.
44. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006a; 66: 41-8. (Pubitemid 43739589)
45. Josephs KA, Stroh A, Dugger B, Dickson DW. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 2009; 118: 349-58.
46. Kertesz A. Pick complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration and progressive supranuclear palsy. Neurologist 2003; 9: 311-7. (Pubitemid 37484850)
47. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005. (Pubitemid 41253267)
48. Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol 2006; 59: 156-65. (Pubitemid 43042882)
49. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 2005; 57: 480-8. (Pubitemid 40471156)
50. Kukull WA, Larson EB, Reifler BV, Lampe TH, Yerby MS, Hughes JP. The validity of three clinical diagnostic criteria for Alzheimer's disease. Neurology 1990; 40: 1364-9. (Pubitemid 20291641)
51. Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, et al. Volumes of hippocampus, amygdala and frontal-lobe in Alzheimer patients with different apolipoprotein-E genotypes. Neuroscience 1995; 67: 65-72.
52. Levine DN, Lee JM, Fisher CM. The visual variant of Alzheimer's disease. Neurology 1993; 43: 305-13.
53. Ling H, O'Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 2010; 133: 2045-57.
54. Litvan I, Bhatia KP, Burn D, Goetz CG, Lang AE, McKeith I, et al. SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003; 18: 467-86. (Pubitemid 36656531)
55. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246 (Suppl 2): 1-5.
56. Llado A, Sanchez-Valle R, Rey MJ, Ezquerra M, Tolosa E, Ferrer I, Molinuevo JL. Clinicopathological and genetic correlates of frontotem-poral lobar degeneration and corticobasal degeneration. J Neurol 2008; 255: 488-94.
57. Lund and Manchester groups. Consensus on clinical and neuropatho-logical criteria for fronto-temporal dementia. J Neurol Neurosurg Psychiatry 1994; 4: 416-8.
58. Mackenzie IRA, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, et al. Heterogeneity of ubiquitin pathology in frontotem-poral lobar degeneration: classification and relation to clinical pheno-type. Acta Neuropathol 2006; 112: 539-49. (Pubitemid 44550678)
59. Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011; 122: 111-13.
60. Mackenzie IRA, Neumann M, Bigio E, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 2009; 117: 15-18.
61. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations: an update. Acta Neuropathol 2010; 119: 1-4.
62. Martin A. Neuropsychology of Alzheimer's disease: the case for subgroups. In: Schwartz MF, editor. Modular deficits in Alzheimer-type dementia. Cambridge, MA: The MIT Press; 1990. p. 143-75.
63. Martin A, Brouwers P, Lalonde F, Cox C, Teleska P, Fedio P, et al. Towards a behavioral typology of Alzheimer's patients. J Clin Exp Neuropsychol 1986; 8: 594-610. (Pubitemid 17185347)
64. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005; 65: 1863-72. (Pubitemid 43970103)
65. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology 1996; 47: 1113-24.
66. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984; 34: 939-44. (Pubitemid 14076461)
67. McNeill R, Sare GM, Manoharan M, Testa HJ, Mann DMA, Neary D, et al. Accuracy of SPECT in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78: 350-5. (Pubitemid 46580539)
68. Mesulam M-M. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982; 11: 592-8. (Pubitemid 12116420)
69. Mesulam M-M. Primary progressive aphasia. Ann Neurol 2001; 49: 425-32.
70. Mesulam M-M, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008; 63: 709-19. (Pubitemid 351945530)
71. Mesulam M, Wieneke C, Rogalski E, Cobia D, Thompson C, Weintraub S. Quantitative template for subtyping primary progressive aphasia. Arch Neurol 2009; 66: 1545-51.
72. Miller BL, Cummings JL, Villanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, Mena I. Frontal lobe degeneration: clinical, neuropsycho-logical and SPECT characteristics. Neurology 1991; 41: 1374-82.
73. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94. (Pubitemid 27304784)
74. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer's disease. Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86.
75. Neary D, Snowden JS, Bowen DM, Sims NR, Mann DMA, Benton JS, et al. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 1986; 49: 163-74. (Pubitemid 16155690)
76. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
77. Neary D, Snowden JS, Mann DMA. Frontotemporal dementia. Lancet Neurol 2005; 4: 771-80. (Pubitemid 41457293)
78. Neary D, Snowden JS, Mann DMA, Northen B, Goulding PJ, MacDermott N. Frontal lobe dementia and motor neurone disease. J Neurol Neurosurg Psychiatry 1990; 53: 23-32. (Pubitemid 20034359)
79. Neary D, Snowden JS, Northen B, Goulding PJ. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51: 353-61. (Pubitemid 18097567)
80. 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987; 50: 1101-9. (Pubitemid 17137818)
81. Okazaki K, Fu YJ, Noshihira Y, Endo M, Fukushima T, Ikeuchi T, et al. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Neuropathology 2010; 30: 140-8.
82. Paviour DC, Lees AJ, Josephs KA, Ozawa T, Ganguly M, Strand C, et al. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 2004; 127: 2441-51. (Pubitemid 39472972)
83. Perry RJ, Hodges JR. Differentiating frontal and temporal variant fronto-temporal dementia from Alzheimer's disease. Neurology 2000; 54: 2277-84. (Pubitemid 30416278)
84. Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, Richardson AMT, et al. Frequency and clinical characteristics of pro-granulin mutation carriers in the Manchester Frontotemporal Lobar Degeneration cohort: comparison to patients with MAPT and no known mutations. Brain 2008; 131: 721-31. (Pubitemid 351294717)
85. Pogacar S, Williams RS. Alzheimer's disease presenting as slowly progressive aphasia. R I Med J 1984; 67: 181-5.
86. Price BH, Gurvit H, Weintraub S, Geula C, Leimkuhler E, Mesulam M. Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease. Arch Neurol 1993; 50: 931-7. (Pubitemid 23275121)
87. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Ab Amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008; 64: 388-401.
88. Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, Pagliaro TA, et al. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers dis other demen 2007; 22: 474-88.
89. Rohrer JD, Ridgway GR, Crutch SJ, Hailstone J, Goll JC, Clarkson MJ, et al. Progressive logopenic/phonological aphasia: erosion of the language network. Neuroimage 2010; 49: 984-93.
90. Ross SJ, Graham N, Stuart-Green L, Prins M, Xuereb J, Patterson K, et al. Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61: 388-95. (Pubitemid 26355781)
91. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohisto-chemistry and novel monoclonal antibodies. Am J Pathol 2006; 169: 1343-52. (Pubitemid 351194368)
92. Scaravilli T, Tolosa E, Ferrer I. Progressive supranuclear palsy and corti-cobasal degeneration: lumping versus splitting. Mov Disord 2005; 20: S21-8. (Pubitemid 41419551)
93. Schott JM, Ridha BH, Crutch SJ, Healy DG, Uphill JB, Warrington EK, et al. Apolipoprotein E genotype modifies the phenotype of Alzheimer's disease. Arch Neurol 2006; 63: 155-6. (Pubitemid 43063881)
94. Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life? Mov Disord 2009; 24: 1593-9.
95. Snowden JS, Bathgate B, Varma A, Blackshaw A, Gibbons ZC, Neary D. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 2001; 70: 323-32. (Pubitemid 32250888)
96. Snowden JS, Goulding PJ, Neary D. Semantic dementia: a form of circumscribed cerebral atrophy. Behav Neurol 1989; 2: 167-82.
97. Snowden JS, Hu Q, Rollinson S, Halliwell N, Robinson A, Davidson YS, et al. The most common type of FTLD-FUS (aFTLD-U) pathology is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol 2011.
98. Snowden JS, Neary D. Progressive anomia with preserved oral spelling and automatic speech. Neurocase 2003; 9: 27-43. (Pubitemid 36781060)
99. Snowden JS, Neary D, Mann DMA. Frontotemporal lobar degeneration: frontotemporal dementia, progressive aphasia and semantic dementia. London: Churchill Livingstone; 1996.
100. Snowden JS, Neary D, Mann DMA. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 2007c; 114: 31-8. (Pubitemid 47029057)
101. Snowden JS, Neary D, Mann DMA, Goulding PJ, Testa HJ. Progressive language disorder due to lobar atrophy. Ann Neurol 1992; 31: 174-83.
102. Snowden JS, Pickering-Brown SM, Du Plessis D, Mackenzie IRA, Varma A, Mann DMA, et al. Progressive anomia revisited: focal degeneration associated with progranulin gene mutation. Neurocase 2007b; 13: 366-77.
103. Snowden JS, Stopford CL, Julien CL, Thompson JC, Davidson Y, Gibbons L, et al. Cognitive phenotypes in Alzheimer's disease and genetic risk. Cortex 2007a; 43: 835-45. (Pubitemid 47520450)
104. Stopford CL, Snowden JS, Thompson JC, Neary D. Distinct memory profiles in Alzheimer's disease. Cortex 2007; 43: 846-57. (Pubitemid 47517037)
105. Stopford CL, Snowden JS, Thompson JC, Neary D. Variability in cognitive presentation of Alzheimer's disease. Cortex 2008; 44: 185-95. (Pubitemid 351729233)
106. Talbot PR, Snowden JS, Lloyd JJ, Neary D, Testa HJ. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol 1995; 242: 579-86.
107. Tartaglia MC, Sidhu M, Laluz C, Racine C, Rabonovici GD, Creighton K, et al. Sporadic corticobasal syndrome due to FTLD-TDP. Acta Neuropathol 2011; 119: 365-74.
108. Thompson JC, Stopford C, Snowden JS, Neary D. Qualitative neuro-psychological performance characteristics in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005; 76: 920-7. (Pubitemid 40909548)
109. Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 2008; 67: 555-64. (Pubitemid 351787082)
110. Warrington EK, James M. Visual Object and Space Perception Battery (VOSP). Oxford: Pearson Assessment; 1991.
111. Zadikoff C, Lang A. Apraxia in movement disorders. Brain 2005; 128: 1480-97. (Pubitemid 41373669)
112. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-68.